Flora Growth (NASDAQ:FLGC) Issues Earnings Results, Misses Expectations By $0.31 EPS

Flora Growth (NASDAQ:FLGC) posted its quarterly earnings data on Monday. The company reported ($0.42) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.31), Zacks reports. Flora Growth had a negative return on equity of 268.17% and a negative net margin of 30.99%.

Flora Growth Stock Up 5.9 %

NASDAQ:FLGC traded up $0.04 during mid-day trading on Monday, reaching $0.66. The stock had a trading volume of 91,166 shares, compared to its average volume of 436,485. Flora Growth has a 12 month low of $0.59 and a 12 month high of $2.93. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.64 and a current ratio of 1.02. The stock has a 50-day simple moving average of $0.81 and a two-hundred day simple moving average of $1.18.

Analysts Set New Price Targets

Separately, Aegis started coverage on Flora Growth in a research report on Monday, November 25th. They issued a “buy” rating and a $4.00 price target on the stock.

Flora Growth Company Profile

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.